What are you looking for? Search Common searches: Departments, Hospitalisation, Professionals, Outpatient clinics, Health advice, Accreditations, Diseases, Diagnostic tests, Treatments, The birth of a child, Emergency, Visiting patients, Fulltext search Tipus de contingut Services and units Professionals Pathologies Health advices Health and wellness Diagnostic tests Treatments News Activities Centers - Any - Search News A single dose of attenuated vaccines could protect multiple sclerosis patients before starting immunosuppressive therapy This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment. Professionals Susana Otero - News The HITIHE project concludes with a meeting of all project members in Antwerp As part of the initiative, WikiTropica, a tool that provides health professionals with up-to-date information on infectious and tropical diseases, has been launched. News Vall d'Hebron discovers a new antibody in patients with scleroderma that will help in the diagnosis of this disease Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer. Professionals Ingrid Faura Sóc infermera gestora de la Unitat de Patologia Mamària de l'Hospital Universitari Vall d'Hebron. Activities Curso de Glaucoma Aula Vall d'Hebron Secretaría Técnica actividades formativas externas Mail: inscripcions@aulavallhebron.cat tel: 693.785.436 News VHIR successfully passes CERCA evaluation The evaluation committee has highlighted that VHIR has experienced a positive evolution in the last evaluation period. News Manina Medtech, Vall d’Hebron spin-off, closes an investment round to develop a medical device to increase the success of In Vitro Fertilization After carrying out a first feasibility trial in collaboration with the Assisted Reproduction Section of the Vall d'Hebron Hospital, Manina Medtech is moving towards a pilot trial in IVF patients. News La Marató finances three Vall d'Hebron projects in cardiovascular health The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments. News The opinion of patients with multiple sclerosis is key to designing a tool that helps shared decision-making A study, led by Vall d'Hebron, identifies what type of information patients need to develop a web platform that will be useful to them when involving- se in making decisions about their treatment. Pagination Previous page ‹‹ Page 210 Next page ››